The rise of drug prices: What will US payers do next?

The rise of drug prices: What will US payers do next?

Lev Gerlovin
Life Sciences

Lev Gerlovin explores the future of payer response to rising drug prices and discuss strategies that manufacturers may consider to gain a competitive edge in this evolving landscape. 

Download PDF